, the converted products selectively reproduced both characteristics, with the DY conversion product being smaller in size and less resistant to PK digestion than the HY product. These data demonstrate that non-mammalian sources of recombinant HaPrP can be converted into PKresistant form and that strain-mediated properties can be transmitted into the newly formed PrP-res.
Introduction
The transmissible spongiform encephalopathies (TSEs) are a group of unusual neurodegenerative diseases that include Creutzfeldt-Jakob disease, fatal familial insomnia, GerstmannStra$ ussler-Scheinker syndrome and kuru in humans, as well as scrapie in sheep, transmissible mink encephalopathy (TME) and bovine spongiform encephalopathy. These diseases are characterized by the accumulation of abnormal aggregated isoforms of the prion protein (PrP Sc ) in affected animals. The crucial pathogenic event in TSE diseases appears to be the conformational transition of the normal cellular PrP (PrP C ) into PrP Sc . PrP Sc forms insoluble aggregates that are proteaseresistant and that have higher β-sheet content than PrP C . Although the biochemical basis for the conversion of PrP C to PrP Sc remains unknown, direct PrP C -PrP Sc interactions appear to be involved (Caughey & Chesebro, 1997) . Current models for PrP Sc replication include template-assisted conversion (Prusiner, 1991) , in which the conformational transition of PrP C Author for correspondence : Judd Aiken.
Fax j1 608 262 7420. e-mail aiken!ahabs.wisc.edu is induced by a monomeric PrP Sc through a cycle of unfolding and refolding reactions, and nucleation-dependent polymerization (Jarrett & Lansbury, 1993) , where infectious PrP Sc is an ordered aggregate that acts as a nucleant. PrP C , upon binding to the seed, acquires the conformation of the PrP Sc polymer.
According to the conformational hypothesis of strain variation, distinct PrP Sc infectious conformers are able to impart their particular properties onto host PrP C . PrP Sc conformations are an important component of TSE strain diversity Collinge et al., 1996 ; Telling et al., 1996 ; Hill et al., 1997 ; Rubenstein et al., 1998 ; Safar et al., 1998 ; Aucouturier et al., 1999 ; Kuczius & Groshup, 1999 ; Bartz et al., 2000) , suggesting that different biochemical properties of PrP Sc account for the strain phenotypes observed in vivo.
The in vitro assay for the conversion reaction of PrP C to PrP Sc , in the presence of exogenous PrP Sc (Kocisko et al., 1994) , reproduces several biological properties of the in vivo TSE infection such as strain-diversity, species-specificity and PrP polymorphism barrier phenomena (Bessen et al., 1995 ; Raymond et al., 1997 ; Bossers et al., V. Iniguez and others V. Iniguez and others 1997). In the present study, recombinant HaPrP C , expressed in a non-mammalian system (baculovirus-infected insect cells), was readily converted to a proteinase K (PK)-resistant form in a cell-free system. These conversion reactions were performed using PrP Sc purified from two strains of hamster-adapted TME in combination with $&S-labelled recombinant hamster (Ha)PrP C ($&S-bacHaPrP C ). In addition to the distinguishing PK cleavage site (Bessen et al., 1995) , another strain-specific property of hamster-adapted TME, differential PK resistance, was found to be transmitted to the newly converted $&S-bacHaPrP-res. These studies show that recombinant PrP from a non-mammalian source can be converted into PrP-res forms, whose properties mimic in vivo PrP Sc .
Methods
Plasmid construction. A 781 bp DNA fragment containing the entire 254 amino acid hamster PrP C open reading frame was amplified from hamster genomic DNA using the primers Shp1 (k14 to j33 : 5h GCAGATCAGCCATCATGGCGAACCTTAGCTACTGGCTGCT-GGCACTC 3h) and Shp2 (j734 to j767 : 5h CCCATCCCCAT-GAGAAAAATGA 3h). The PCR fragment was ligated into the baculovirus transfer vector pBlueBacIII (Invitrogen) using BglI and PstI unique restriction sites, producing the recombinant vector pBlueBacIIIHaPrP C .
Cell and virus culture. Cultures of Spodoptera frugiperda (Sf21 cells) were cotransfected with the pBlueBacIII-HaPrP C construct and linearized baculovirus DNA using the Invitrogen Bac-N-Blue transfection kit. Seventy-four purified plaques of the recombinant virus were used to infect Sf21 cultures and screened for expression of bacHaPrP C by SDS-PAGE and Western immunoblotting using the anti-PrP monoclonal antibody 3F4 (Kascsak et al., 1987) . One stable, high expression virus (BacIII-HaPrP C ) was selected and used for the remainder of the study. (Sigma) . The cells were lysed in ice with LB buffer (0n05 M Tris-HCl, pH 7n4; 0n15 M NaCl ; 0n5 % Triton X-100 ; 0n5 % sodium deoxycholate) and the radiolabelled proteins were immunoprecipitated in buffer A [0n05 M Tris-HCl, pH 8n2; 0n15 M NaCl ; 2 % (w\v) Nlaurylsarcosine ; 0n4% (w\v) lecithin] using the 3F4 antibody and protein A-Sepharose beads . The $&S-bacHaPrPC was eluted from the antibody-protein A-Sepharose complex in 0n1 M acetic acid and stored at 4 mC (Kocisko et al., 1996) . Animal bioassay. BacHaPrP C was tested for infectivity using an animal bioassay. Syrian Golden hamsters (n l 8) were intracerebrally inoculated with 200-250 ng of the recombinant protein in PBS (50 µl). Hamsters were monitored for clinical signs of TSE for 400 days.
Isolation of PrP

Sc
. PrP Sc -enriched fractions were prepared from the brains of Syrian Golden hamsters (infected with either the hyper or drowsy strain of hamster-adapted TME) as described .
Protein concentration assay. Protein concentrations were measured with the Bio-Rad protein assay.
Cell-free conversion reaction. PrP Sc -enriched preparations (1-2 mg\ml) were partially denatured by incubation in 2n5 M guanidine hydrochloride (Gdn-HCl) for 7 h at 37 mC. Aliquots of denatured PrP Sc (2-3 µg) and the $&S-bacHaPrPC solution (50 ng) were mixed, diluted to 1 M Gdn-HCl in conversion buffer (1 % N-laurylsarcosine ; 5 mM cetylpyridinium chloride ; 50 mM sodium citrate, pH 6n0), sonicated for 10 s and incubated at 37 mC for 2 days . To measure proteinase K resistance to PK, the samples were treated with 25 µg\ml PK at 37 mC for 1 h. A PK inhibitor (Pefabloc ; Boehringer Mannheim) and 20 µg of a carrier protein (thyroglobulin) were added and the proteins were precipitated in 4 vols of methanol at k20 mC. The resulting pellet was boiled in sample buffer and fractionated by SDS-PAGE. Conversion of $&S-bacHaPrPC was analysed by the presence and size of the protease-resistant $&S-labelled material ($&S-bacHaPrPres) by autoradiography and quantified using a Phosphoimager (Molecular Dynamics) and ImageQuant software.
Results
Expression and characterization of HaPrP C in baculovirus-infected cells
HaPrP C was synthesized in insect cells infected with recombinant virus BacIII-HaPrP C . Cell lysates were analysed by Western blot analysis using an anti-PrP monoclonal antibody, 3F4. The recombinant protein exhibited a molecular mass of 26-30 kDa ( Fig. 1 A) . The protein was detected as early as 16 h post-infection (p.i.) ( Fig. 1 B) and was largely virion-associated at 3 days p.i. The yield (quantified by Western blot analysis) was approximately 5 mg of HaPrP C per litre of culture medium.
The baculovirus expression system produced a proteasesensitive-PrP C (PrP-sen) that was completely degraded after PK treatment (25 µg\ml, 1 h, 37 mC ; Fig. 1 A) . BacHaPrP C was not infectious as no clinical symptoms of scrapie were observed in hamsters inoculated intracerebrally with the recombinant protein ( 1 year).
Conversion of bacHaPrP C to protease-resistant form
To determine whether bacHaPrP C could act as a substrate for conversion to a PK-resistant form in a cell-free system, $&S- bacHaPrP C was incubated for 2 days with partially denatured PrP HY . PK-resistant $&S-bacHaPrPC was observed after PK digestion. The PK digestion products exhibited a 6-7 kDa decrease in molecular mass as expected for PK cleavage of PrP Sc (Fig. 2 A) . $&S-bacHaPrPC incubated under the same conditions in the absence of PrP Sc -enriched preparations was completely digested by PK (Fig. 2 A) , indicating that the conversion was PrP Sc -dependent. The conversion efficiencies of $&S-bacHaPrPC to $&S-bacHaPrP-res were " 25-30 %. $&S -PrP-res products were not observed when more extensively denatured PrP Sc (6 M Gdn-HCl) was used in the reaction (data not shown). The conversion of bacHaPrP C into proteaseresistant forms increased as a function of time (Fig. 2 A, B) . Serial dilution of the PrP Sc -enriched preparations resulted in the absence of conversion at PrP Sc concentrations below 100 µg\ml (Fig. 2 C) , suggesting that a critical PrP Sc concentration was required for conversion.
Strain specificity of the conversion reaction
The hyper and drowsy strains of hamster-adapted TME produce strain-specific abnormal PrP that can be distinguished after PK digestion. PrP HY , upon PK digestion, is 1-2 kDa larger in size than similarly treated PrP DY (Fig. 3 A) a, b, 1994 Caughey et al., 1998) . To determine whether bacHaPrP C was converted in a similar manner, we performed experiments using abnormal PrP from each strain. PrP HY -and PrP DY -enriched preparations drove the conversion of $&S-bacHaPrPC into products with the sizes predicted after PK digestion. The observed 1-2 kDa size difference in the converted products after protease digestion (Fig. 3 B) was reproducible using four independent PrP HY -and four independent PrP DY -enriched preparations.
Another distinguishing characteristic of PrP HY and PrP DY is the increased susceptibility of PrP DY to protease digestion (Bessen & Marsh, 1994) . PK digestion (100 µg\ml, 37 mC) results in an 80 % reduction of in vivo generated PrP DY after 1 h, whereas a similar reduction in PrP HY requires 48 h (Bessen & Marsh, 1994) . To determine whether this characteristic was also transferred from PrP Sc to radiolabelled bacHaPrP C , a PKdigestion time-course (0n5-2 h, 50 µg\ml, 37 mC) and protease digestion under increasing concentrations of PK (25-100 µg\ml for 1 h at 37 mC) of the strain-specific converted products were performed. In both sets of experiments, the DYderived $&S-bacHaPrP-res product was less resistant to PK digestion than the HY-derived product (Fig. 4 A, B) . To further characterize the differential PK sensitivity, the effect of V. Iniguez and others V. Iniguez and others . The conversion products driven by PrP HY and PrP DY display differences in the PK-cleavage site as well as the relative resistance to PK. Molecular mass markers are indicated to the right. (A) Converted products driven by PrP HY and PrP DY . PK-digestion time-course of the conversion products driven by equivalent amounts of PrP HY and PrP DY . Conversion reactions were digested with PK (50 µg/ml) at 37 mC for increasing periods of time (30 min-2 h). The presence of minor converted products can be observed in both reactions. (B) Converted products driven by PrP HY and PrP DY . Conversion reactions driven by equivalent amounts of PrP HY and PrP DY were digested with increasing concentrations of PK (25-100 µg/ml, 1 h, 37 mC). The presence of minor converted products can be observed in both reactions. (C) Percentage of remaining PK resistance of the converted products (data represent an average of three independent reactions pstandard deviations). Conversion reactions were divided into three equal aliquots and digested with 25, 50 or 100 µg/ml PK (1 h, 37 mC). The percentage of remaining PK resistance represents the percentage of 35 SbacHaPrP-res [% conversion l (vol. of proteasekresistant radiolabelled material)/(vol. of undigested PrP)i100] obtained after PK digestions (at 50 and 100 µg/ml) normalized to the percentage of 35 S-bacHaPrP-res present at 25 µg/ml. Shaded and black bars represent conversion products driven by PrP HY and PrP DY , respectively.
increasing PK concentrations was measured between the strain conversion products. The percentage of PK-resistant material obtained after PK digestions (25, 50 and 100 µg\ml for 1 h at 37 mC) was quantified and normalized as a percentage to the amount present at 25 µg\ml. As shown in Fig. 4 (C) , the percentage of the DY-derived $&S-bacHaPrP-res product that remained resistant to 50 and 100 µg\ml PK was significantly lower (P 0n05, Student's t-test) than the HY-converted material under both conditions. These results suggest that the PK-resistant material generated by the in vitro conversion of $&S-bacHaPrPC into $&S-bacHaPrPHY and $&S-bacHaPrPDY exhibited two defining strain characteristics : (i) differential PK cleavage site and (ii) differing susceptibility to PK digestion.
Discussion
The purification difficulties and low yield of cellular PrP C obtained from brain tissue (Turk et al., 1988 ; Pergami et al., 1996) has led to the use of various recombinant expression systems including E. coli (Weiss et al., 1995 ; Mehlhorn et al., CFGI 1996 ; Hornemann et al., 1997 ; Negro et al., 1997) , yeast (Weiss et al., 1995) , baculovirus (Scott et al., 1988 ; Weiss et al., 1995) and mammalian cell culture (Chesebro et al., 1993 ; Priola et al., 1995 ; Hill et al., 1999) for the production of PrP C . We report here the expression of HaPrP C in baculovirus-infected insect cells. The expressed protein, containing a processed full-length form of HaPrP (23-231), displayed predominantly a molecular mass of 27 kDa corresponding to the unglycosylated HaPrP C form. The presence of partially glycosylated minor isoforms were also observed (28-30 kDa) but in much lower quantities. In contrast, HaPrP C obtained from uninfected brain tissues has a molecular mass of 33-35 kDa (Oesch et al., 1985) , as a result of GPI anchor addition and glycosylation. These findings suggest that insect cell lines do not generate the complex posttranslational modifications present in mammalian cells. Similar results were obtained using a different baculovirus expression vector (Scott et al., 1988) .
The ' prion hypothesis ' predicts that PrP Sc display selfconverting activity by interacting with PrP C (Prusiner, 1998) . We tested the ability of bacHaPrP to acquire a PrP Sc -like conformation in the presence of PrP Sc -enriched preparations. Since previous cell-free conversion experiments used recombinant PrP C expressed in mammalian cell lines or PrP immunoprecipitated from brain homogenates, it is possible that other putative factor(s) may copurify with the prion protein and affect these reactions (Westaway et al., 1998) . A number of studies have shown that bacterial chaperones (DebBurman et al., 1997) , transition metals (McKenzie et al., 1998 (McKenzie et al., , 1999 and cell lysates (Saborio et al., 1999) can facilitate the in vitro formation of PK-resistant protein. Our data demonstrate that recombinant HaPrP C synthesized in a nonmammalian expression system can be converted in vitro into PK-resistant form upon interaction with PrP Sc -enriched preparations. Since $&S-bacHaPrPC and PrP Sc molecules constituted the main components of the assay, our data indicate that the formation of PrP-res is the result of the PrP Sc self ability to propagate. These results also reinforce the specificity of the PrP C -PrP Sc interactions and the utility of the cell-free assay, although they do not eliminate the possible requirement of accessory molecules that may be essential and\or influence PrP-res formation. Similar to conversion studies using mammalian HaPrP C (Kocisko et al., 1994 ; Bessen et al., 1995) , post-translational modifications of PrP C do not seem to be required for the conversion reaction. This suggests that, independent of the cell source where the primary polypeptide was expressed, the conformation(s) imposed by the primary HaPrP sequence is sufficient for its ability to act as a substrate in the in vitro assay. Correspondingly, the converting activity of PrP Sc was also functional upon interacting with bacHaPrP C . Our data, therefore, represent the first study of functional PrP Sc -converting activity of non-mammalian derived HaPrP C .
The acquisition of PK resistance of baculovirus-expressed HaPrP C upon incubation with partially denatured PrP Sc , including the specific PK-cleavage site characteristic of PrP Sc , is time-dependent and requires a critical PrP Sc concentration. This pattern was consistent with other studies , indicating that PrP Sc aggregates are critical for converting activity and support the nucleated polymerization model for the PrP C -to-PrP Sc transition (Harper & Lansbury, 1997) . The slight size increase of the converted material observed during the time-course of $&S-bacHaPrP-res formation (Fig. 2 A) suggests that, in the early stages of the reaction, the converted material adopts a conformation that is less structured and, therefore, more accessible to PK digestion. Efficiency levels for the formation of $&S-bacHaPrP-res (25-30 %) are comparable to cell-free conversions using mammalian cell-derived recombinant PrP C Raymond et al., 1997 ; Bossers et al., 1997) . In some conversion reactions, two different bands were observed (Fig.  2 C) , possibly a result of gel running conditions.
To further characterize the specificity of the cell-free conversion assay using baculovirus-expressed PrP C , PrP HYand PrP DY -enriched preparations were tested for their ability to convert bacHaPrP C into strain-specific products. We characterized the conversion through the analysis of two strain-specific biochemical markers, the molecular size difference after PK digestion and the degree of PK resistance. As a result of conversion of recombinant PrP C driven by either PrP HY or PrP DY , the converted material displays not only the electrophoretic mobility shift characteristic for each strain after PK digestion (Bessen et al., 1995) but also the relative resistance to PK. These data indicate that, upon propagation of the PrP Scstate, insect cell-derived HaPrP can acquire different PrP Sc conformations and that strain-specific PrP-res properties can be also reproduced when this source of PrP was used as a conversion substrate. The acquisition of both strain biochemical properties by the $&S-bacHaPrPC and the fact that these properties rely on the PrP Sc conformation strongly suggest that in vivo derived PrP Sc can specifically propagate its own strain-specific conformation into bacHaPrP. Our results provide additional evidence that the cell-free assay reproduces, in vitro and at the molecular level, strain properties of hamsteradapted TME agent.
In hamster-adapted TME, PrP DY accumulates at a slower rate than PrP HY (McKenzie et al., 1996) . These observations could result from strain-specific differences in conformational conversion rates and\or metabolic clearance of the converted products. The efficiency of conversion using our standard PK digestion treatment (25 µg\ml, 1 h, 37 mC) was 25-30 % (p7 %) in both PrP HY -and PrP DY -derived products. Under these conditions, we do not observe differences in conversion activity between the two strains. There is, however, a remarkable effect on the strain-properties of the converted products when higher concentrations of PK or longer proteasedigestion periods are used (Fig. 4) . As time of digestion and\or PK concentration increase (50-100 µg\ml), the $&S-DY-like converted product exhibits a higher susceptibility to PK (Fig. 4 CFGJ V. Iniguez and others V. Iniguez and others A-C). These results suggest that the strain-derived products do not have distinguishing converting efficiencies but rather conformational differences that determine their stability and accessibility to PK cleavage. Therefore, our data argue that differential turnover of PrP HY and PrP DY could account for the differences observed in the incubation period upon their transmission into hamsters. In contrast to these observations, Bessen et al. (1995) reported different converting efficiencies between the strain-specific converted products. Furthermore, the investigators did not detect differences in PK sensitivity in the converted products. The discrepancies with our observations are perhaps the result of different experimental conditions used in the assay (conversion buffer composition, recombinant HaPrP source, PK concentrations and digestion times). It should be emphasized that, similar to our findings, in vivo PrP HY is more resistant to PK than PrP DY .
Although the infectious nature of the converted products remains to be determined, we have demonstrated that recombinant HaPrP expressed in non-mammalian systems can be converted in vitro into PrP-res in the presence of PrP Sc . Moreover, conformational differences between PrP HY and PrP DY that account for their strain-specific biochemical properties were faithfully transferred into insect cell-derived-HaPrP. Altogether these data support the self-propagating activity of PrP Sc . It has been proposed that the in vivo PrP conformational transition requires the presence of molecular chaperones (Prusiner, 1998) . The use of defined components in the conversion reactions should facilitate the identification of potential cofactors involved in PrP Sc formation.
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